Drug Shortage Report for AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

Last updated on 2022-06-03 History
Report ID 159965
Drug Identification Number 02495937
Brand name AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION
Common or Proper name AMOXI-CLAV
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) AMOXICILLIN CLAVULANIC ACID
Strength(s) 2000MG 200MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10PSOIJ
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2022-05-04
Estimated end date 2022-09-02
Actual end date
Shortage status Actual shortage
Updated date 2022-06-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-06-03 French Compare
v6 2022-06-03 English Compare
v5 2022-05-10 French Compare
v4 2022-05-10 English Compare
v3 2022-05-05 English Compare
v2 2022-05-04 French Compare
v1 2022-05-04 English Compare

Showing 1 to 7 of 7